1. Cost-utility of albiglutide versus insulin lispro, insulin glargine, and sitagliptin for the treatment of type 2 diabetes in the US. (2nd July 2016) Authors: Bruhn, David; Martin, Alan A.; Tavares, Ruben; Hunt, Barnaby; Pollock, Richard F. Journal: Journal of medical economics Issue: Volume 19:Number 7(2016) Page Start: 672 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗